Related Experiment Videos
Immunological tolerance to a defined myelin basic protein antigen administered intrathymically
J A Goss1, Y Nakafusa, C R Roland
1Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110.
Journal of Immunology (Baltimore, Md. : 1950)
|November 1, 1994
Summary
Intrathymic injection of myelin basic protein (MBP) with anti-lymphocyte serum prevents experimental autoimmune encephalomyelitis (EAE) by inducing immune tolerance. This method creates functionally unresponsive lymphocytes, blocking autoimmune responses in the central nervous system.
Area of Science:
- Immunology
- Neuroscience
- Autoimmunity
Background:
- Experimental autoimmune encephalomyelitis (EAE) is a model for multiple sclerosis.
- EAE is mediated by myelin basic protein (MBP)-reactive CD4+ T lymphocytes.
- Understanding allograft tolerance mechanisms is crucial.
Purpose of the Study:
- To investigate the mechanisms of tolerance induction after intrathymic (IT) antigen administration.
- To determine if IT injection of alloantigen prevents EAE.
Main Methods:
- Lewis rats received IT, intravenous (IV), or intraperitoneal (IP) injections of guinea pig MBP (GP-MBP) and anti-rat lymphocyte serum.
- Rats were subsequently challenged with GP-MBP to induce EAE.
- Histological analysis and in vitro T cell proliferation assays were performed.
Main Results:
- Only IT administration of GP-MBP plus anti-lymphocyte serum conferred resistance to EAE.
- IT treatment reduced spinal cord infiltrates and GP-MBP-specific T cell proliferation.
- Recombinant interleukin-2 (rIL-2) restored proliferation in IT-treated animals.
Conclusions:
- Intrathymic exposure to MBP induces functional unresponsiveness in lymphocytes.
- This IT administration prevents autoimmune EAE by establishing immune tolerance.
- The findings highlight IT injection as a potential strategy for preventing autoimmune diseases.